ATE226089T1 - Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung - Google Patents
Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilungInfo
- Publication number
- ATE226089T1 ATE226089T1 AT95200208T AT95200208T ATE226089T1 AT E226089 T1 ATE226089 T1 AT E226089T1 AT 95200208 T AT95200208 T AT 95200208T AT 95200208 T AT95200208 T AT 95200208T AT E226089 T1 ATE226089 T1 AT E226089T1
- Authority
- AT
- Austria
- Prior art keywords
- plasminogen activator
- wound healing
- preparation containing
- improving wound
- present
- Prior art date
Links
- 102000001938 Plasminogen Activators Human genes 0.000 title abstract 4
- 108010001014 Plasminogen Activators Proteins 0.000 title abstract 4
- 229940127126 plasminogen activator Drugs 0.000 title abstract 4
- 230000029663 wound healing Effects 0.000 title 1
- 206010052428 Wound Diseases 0.000 abstract 3
- 208000027418 Wounds and injury Diseases 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 230000035876 healing Effects 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 230000007717 exclusion Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95200208A EP0723782B1 (de) | 1995-01-27 | 1995-01-27 | Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226089T1 true ATE226089T1 (de) | 2002-11-15 |
Family
ID=8219975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95200208T ATE226089T1 (de) | 1995-01-27 | 1995-01-27 | Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5925350A (de) |
| EP (1) | EP0723782B1 (de) |
| JP (1) | JP3980088B2 (de) |
| AT (1) | ATE226089T1 (de) |
| DE (1) | DE69528573T2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4149378B2 (ja) * | 2001-06-29 | 2008-09-10 | 株式会社資生堂 | 複合粉体、及びそれを配合した皮膚外用剤 |
| US7067492B2 (en) | 2001-09-06 | 2006-06-27 | Omnio Ab | Method of promoting healing of a tympanic membrane perforation |
| US7202066B2 (en) * | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
| WO2004009111A1 (ja) * | 2002-07-19 | 2004-01-29 | Santen Pharmaceutical Co., Ltd. | 角膜上皮障害治癒促進剤 |
| WO2005040194A2 (en) * | 2003-10-24 | 2005-05-06 | Ludwig Institute For Cancer Research | Methods and compositions for pdgf-c activation and inhibition |
| US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
| US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
| US20070128685A1 (en) * | 2005-07-01 | 2007-06-07 | Rodolfo Faudoa | Methods and compositions for cell culture |
| IN2015MN00047A (de) | 2012-07-05 | 2015-10-16 | Hadasit Med Res Service | |
| ES2523458B1 (es) * | 2013-05-23 | 2015-07-15 | José Manuel GALEANO SALVADOR | Composición farmacéutica o cosmética para la regeneración y cicatrización de la piel |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU586306B2 (en) * | 1985-12-16 | 1989-07-06 | Ethicon Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
| US5364622A (en) * | 1987-12-04 | 1994-11-15 | Dr. Karl Thomae Gmbh | Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel |
| US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
| DE4411143C2 (de) * | 1994-03-30 | 1996-08-01 | Immuno Ag | Thrombosemittel |
-
1995
- 1995-01-27 AT AT95200208T patent/ATE226089T1/de not_active IP Right Cessation
- 1995-01-27 DE DE69528573T patent/DE69528573T2/de not_active Expired - Fee Related
- 1995-01-27 EP EP95200208A patent/EP0723782B1/de not_active Expired - Lifetime
-
1996
- 1996-01-26 JP JP01208796A patent/JP3980088B2/ja not_active Expired - Lifetime
-
1997
- 1997-08-04 US US08/905,874 patent/US5925350A/en not_active Expired - Fee Related
-
1998
- 1998-11-10 US US09/189,524 patent/US6033664A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69528573D1 (de) | 2002-11-21 |
| JP3980088B2 (ja) | 2007-09-19 |
| US6033664A (en) | 2000-03-07 |
| EP0723782A1 (de) | 1996-07-31 |
| DE69528573T2 (de) | 2003-06-18 |
| US5925350A (en) | 1999-07-20 |
| EP0723782B1 (de) | 2002-10-16 |
| JPH08253425A (ja) | 1996-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE196604T1 (de) | Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung | |
| ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
| DE69734661D1 (de) | Foerderung der wundheilung durch chemisch modifizierte tetracycline | |
| DE69634430D1 (de) | Formulierung fur die wundheilung mit menschlichem plasma fibronektin | |
| AU5094985A (en) | Wound healing agents | |
| DE59911740D1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
| DE69627680D1 (de) | Verwendung von kohlehydraten zur foerderung der schuppenden haut | |
| AU7625196A (en) | Bandaging system | |
| DE69528573D1 (de) | Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung | |
| ATE192924T1 (de) | Liposomal verkapseltes taxol, seine herstellung und seine verwendung | |
| ATE232393T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung | |
| ATE306921T1 (de) | Verwendung von cs-866 (olmersartan) zur herstellung eines medikaments für die behandlung von arteriosklerose | |
| ATE79536T1 (de) | Tamoxifen zur topischen verwendung. | |
| DE69330727D1 (de) | Gefriergetrockneter Verband | |
| ATE223228T1 (de) | Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. | |
| ATE236638T1 (de) | Neue verwendung von prostaglandinen | |
| ATE141794T1 (de) | Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen | |
| DE68905342D1 (de) | Verwendung von minoxidil zur wundheilung. | |
| ES540447A0 (es) | Un metodo de preparar un vendaje | |
| GB2347625A (en) | Agent for treating allergic or hypersensivity condition | |
| ATE245443T1 (de) | Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer | |
| AU589283B2 (en) | Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin | |
| DE69600367D1 (de) | Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera | |
| DK277387D0 (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
| RU94024337A (ru) | Антиметастатическое средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0723782 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |